India’s first intra-nasal COVID-19 vaccine by Bharat Biotech gets DCGI approval

Key Points:

• Bharat Biotech's intranasal Covid vaccine got emergency use approval from the Drugs Controller General of India (DCGI). This will be India's first nasal vaccine for COVID-19.
• This step will further strengthen government's collective fight against the pandemic. Under the leadership of Prime Minister Narendra Modi, India has harnessed its science, research and development, and human resources in the fight against COVID-19. 
• This is India's first intranasal vaccine for COVID-19